CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 103 enrolled
Drug / intervention
Anti-hypertensive Medication -drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01669928
NCT01669928Phase 4Completed

Hellenic Anglo Research Into Morning Or Evening Antihypertensive Drug deliverY Trial

Imperial College London·interventional·Posted Aug 21, 2012·Updated Mar 8, 2021

In Brief

A Phase 4 clinical trial evaluating Anti-hypertensive Medication - for Hypertension. Completed, enrolled 103 participants across 2 sites in 2 countries.

Detailed Summary

A randomised crossover trial of anti-hypertensive medication dosing regimen in effective blood pressure control. To investigate whether there is a difference in 24 hour blood pressure (BP) control when antihypertensive medications are taken in the morning compared with the evening.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesGreece, United Kingdom

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 21, 2012
Enrollment StartApr 1, 2012
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.9 years ago

Interventions

Anti-hypertensive Medication -drug

Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication. Dosing regimen either in the morning (between 06.00 and 11.00) or in the evening (between 18.00 and 23.00).